Vol 86, No 2 (2015)
ARTICLES

open access

Page views 1251
Article views/downloads 1102
Get Citation

Connect on Social Media

Connect on Social Media

The role of the Fanconi anemia pathway in the pathophysiology of ovarian cancer

Agnieszka Synowiec, Jolanta Szenajch, Gabriel Wcisło, Cezary Szczylik
DOI: 10.17772/gp/2003
Ginekol Pol 2015;86(2).

Abstract

We reviewed the literature on the relationship between the Fanconi anemia pathway (FA) and response to chemotherapy in patients with ovarian cancer. Despite continuous developments in medicine, ovarian cancer remains a challenge for both, physicians and researchers seeking ways to achieve better results of chemotherapy combined with other targeted therapies. Clinically relevant resistance to chemotherapy is a major problem in treating ovarian cancer. Researchers continue to investigate mechanisms responsible for drug resistance in order to develop better therapeutic methods against ovarian cancer. Among the resistance mechanisms, defects in DNA repair, including the FA pathway, may be important in increasing the sensitivity of ovarian cancer cells to chemotherapy agents at the clinical level. A growing number of data has shown that disruption of the FA genes may be a useful predictor of OC sensitivity to chemotherapy agents whose activity is based on DNA crosslinking mechanisms..

Article available in PDF format

View PDF Download PDF file